+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Biodefense Market 2020-2024 - Product Image

Global Biodefense Market 2020-2024

  • ID: 5031200
  • Report
  • May 2020
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Alexeter Technologies LLC
  • Altimmune Inc.
  • ANP Technologies Inc.
  • Bavarian Nordic AS
  • Cleveland BioLabs Inc.
  • Elusys Therapeutics Inc.
  • MORE
Global Biodefense Market 2020-2024

The biodefense market is poised to grow by $ 3.22 billion during 2020-2024 progressing at a CAGR of 8% during the forecast period. This report on the biodefense market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing threat of bioterrorism, rapid increase in government funding in R&D and recent outbreaks of infectious diseases. In addition, growing threat of bioterrorism is anticipated to boost the growth of the market as well.

The biodefense market analysis includes application segment and geographic landscapes

The biodefense market is segmented as below:

By Application
  • Anthrax
  • Smallpox
  • Botulism
  • Others
By Geographic Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the government initiatives as one of the prime reasons driving the biodefense market growth during the next few years. Also, growing collaborations and M&A and increasing healthcare expenditure will lead to sizable demand in the market.

The biodefense market covers the following areas:
  • Biodefense market sizing
  • Biodefense market forecast
  • Biodefense market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biodefense market vendors that include Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., and GlaxoSmithKline Plc. Also, the biodefense market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The research presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alexeter Technologies LLC
  • Altimmune Inc.
  • ANP Technologies Inc.
  • Bavarian Nordic AS
  • Cleveland BioLabs Inc.
  • Elusys Therapeutics Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Application
  • Market segments
  • Comparison by Application
  • Anthrax - Market size and forecast 2019-2024
  • Smallpox - Market size and forecast 2019-2024
  • Botulism - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive scenario
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Alexeter Technologies LLC
  • Alnylam Pharmaceuticals Inc.
  • Altimmune Inc.
  • ANP Technologies Inc.
  • Bavarian Nordic AS
  • Cleveland BioLabs Inc.
  • Elusys Therapeutics Inc.
  • Emergent BioSolutions Inc.
  • General Dynamics Corp.
  • GlaxoSmithKline Plc
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Application - Market share 2019-2024 (%)
22: Comparison by Application
23: Anthrax - Market size and forecast 2019-2024 ($ million)
24: Anthrax - Year-over-year growth 2019-2024 (%)
25: Smallpox - Market size and forecast 2019-2024 ($ million)
26: Smallpox - Year-over-year growth 2019-2024 (%)
27: Botulism - Market size and forecast 2019-2024 ($ million)
28: Botulism - Year-over-year growth 2019-2024 (%)
29: Others - Market size and forecast 2019-2024 ($ million)
30: Others - Year-over-year growth 2019-2024 (%)
31: Market opportunity by Application
32: Customer landscape
33: Market share by geography 2019-2024 (%)
34: Geographic comparison
35: North America - Market size and forecast 2019-2024 ($ million)
36: North America - Year-over-year growth 2019-2024 (%)
37: Europe - Market size and forecast 2019-2024 ($ million)
38: Europe - Year-over-year growth 2019-2024 (%)
39: Asia - Market size and forecast 2019-2024 ($ million)
40: Asia - Year-over-year growth 2019-2024 (%)
41: ROW - Market size and forecast 2019-2024 ($ million)
42: ROW - Year-over-year growth 2019-2024 (%)
43: Key leading countries
44: Market opportunity by geography ($ million)
45: Impact of drivers and challenges
46: Vendor landscape
47: Landscape disruption
48: Industry risks
49: Vendors covered
50: Market positioning of vendors
51: Alexeter Technologies LLC - Overview
52: Alexeter Technologies LLC - Product and service
53: Alexeter Technologies LLC - Key offerings
54: Alexeter Technologies LLC - Key customers
55: Alexeter Technologies LLC - Segment focus
56: Alnylam Pharmaceuticals Inc. - Overview
57: Alnylam Pharmaceuticals Inc. - Product and service
58: Alnylam Pharmaceuticals Inc. - Key offerings
59: Alnylam Pharmaceuticals Inc. - Key customers
60: Alnylam Pharmaceuticals Inc. - Segment focus
61: Altimmune Inc. - Overview
62: Altimmune Inc. - Business segments
63: Altimmune Inc. - Key offerings
64: Altimmune Inc. - Key customers
65: Altimmune Inc. - Segment focus
66: ANP Technologies Inc. - Overview
67: ANP Technologies Inc. - Product and service
68: ANP Technologies Inc. - Key offerings
69: ANP Technologies Inc. - Key customers
70: ANP Technologies Inc. - Segment focus
71: Bavarian Nordic AS - Overview
72: Bavarian Nordic AS - Business segments
73: Bavarian Nordic AS - Key offerings
74: Bavarian Nordic AS - Key customers
75: Bavarian Nordic AS - Segment focus
76: Cleveland BioLabs Inc. - Overview
77: Cleveland BioLabs Inc. - Product and service
78: Cleveland BioLabs Inc. - Key offerings
79: Cleveland BioLabs Inc. - Key customers
80: Cleveland BioLabs Inc. - Segment focus
81: Elusys Therapeutics Inc. - Overview
82: Elusys Therapeutics Inc. - Product and service
83: Elusys Therapeutics Inc. - Key offerings
84: Elusys Therapeutics Inc. - Key customers
85: Elusys Therapeutics Inc. - Segment focus
86: Emergent BioSolutions Inc. - Overview
87: Emergent BioSolutions Inc. - Business segments
88: Emergent BioSolutions Inc. - Key offerings
89: Emergent BioSolutions Inc. - Key customers
90: Emergent BioSolutions Inc. - Segment focus
91: General Dynamics Corp. - Overview
92: General Dynamics Corp. - Business segments
93: General Dynamics Corp. - Key offerings
94: General Dynamics Corp. - Key customers
95: General Dynamics Corp. - Segment focus
96: GlaxoSmithKline Plc - Overview
97: GlaxoSmithKline Plc - Business segments
98: GlaxoSmithKline Plc - Key offerings
99: GlaxoSmithKline Plc - Key customers
100: GlaxoSmithKline Plc - Segment focus
101: Currency conversion rates for US$
102: Research Methodology
103: Validation techniques employed for market sizing
104: Information sources
105: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Alexeter Technologies LLC
  • Altimmune Inc.
  • ANP Technologies Inc.
  • Bavarian Nordic AS
  • Cleveland BioLabs Inc.
  • Elusys Therapeutics Inc.
  • MORE
The publisher recognizes the following companies as the key players in the global biodefense market: Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., and GlaxoSmithKline Plc.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is government initiatives."

According to the report, one of the major drivers for this market is the growing threat of bioterrorism.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Alexeter Technologies LLC
  • Alnylam Pharmaceuticals Inc.
  • Altimmune Inc.
  • ANP Technologies Inc.
  • Bavarian Nordic AS
  • Cleveland BioLabs Inc.
  • Elusys Therapeutics Inc.
  • Emergent BioSolutions Inc.
  • General Dynamics Corp.
  • GlaxoSmithKline Plc
Note: Product cover images may vary from those shown
Adroll
adroll